Le Lézard
Classified in: Health, Business
Subject: TNM


JOHNSON CITY, Tenn., May 24, 2022 /CNW/ -- Crown Laboratories ("Crown"), a leading, fully integrated global skincare company, has finalized an agreement with Eclipse, a medical technology company, to acquire its global, aesthetics-focused assets. The acquisition expands Crown's aesthetics' product portfolio and enhances Crown's overall value proposition as a global leader in science-based aesthetic skincare solutions.

"We pride ourselves on being at the forefront of today's aesthetics market by developing and delivering best-in-class medical technologies and products that are exceptionally safe and effective," said Jeff Bedard, President and CEO of Crown.  "This strategic acquisition furthers Crown's mission to drive innovation and provide superior products and customer service to aesthetics providers around the world. Eclipse's excellent products will broaden our product line and customer base, domestically and internationally."

"We are thrilled to have completed this transaction with Crown," added Paul O'Brien, CEO of Eclipse. "The combination of Eclipse's innovative product offerings with Crown's leadership position in the aesthetics market will undoubtedly expand the reach and optimize the range of services health care professionals can provide to their patients."

As an innovative company focused on skin science, Crown will integrate the Eclipse products into the Aesthetics business unit of Crown to complement its award-winning SkinPen® Precision and other brands.  Eclipse customers can expect to continue receiving superior customer service, medical education, and access to Crown's expanded range of highly effective aesthetic products.    

About Crown Laboratories, Inc.

Crown, a privately held, fully integrated global skincare company, is committed to developing and providing a diverse portfolio of aesthetic, premium and therapeutic skincare products that improve the quality of life for its consumers throughout their skincare journey. An innovative company focused on skin science for life, Crown's unyielding pursuit of delivering therapeutic excellence and enhanced patient outcomes is why it has become the leader in dermatology and aesthetics. Crown has been listed on the Inc. 5000 Fastest Growing Privately Held Companies List for eight years and has expanded its distribution to over 38 countries. For more information, visit www.crownlaboratories.com.

About Eclipse 

Eclipse was established in January 1993 as a specialty surgical supply company. It quickly became a successful privately held medical device company and one of the pioneers in the aesthetic market, launching several energy-based devices globally. For more than 28 years, Eclipse has been an innovative leader in advancing medical technologies to bring medical supplies to practices in the U.S. and around the globe. Based in Dallas, Eclipse manufactures and distributes high-efficacy, affordable products to physicians that exceed patient expectations and put immediate profit into our partners' practices.

SOURCE Crown Laboratories, Inc.

These press releases may also interest you

at 10:00
Maryland University of Integrative Health (MUIH) will begin offering its...

at 09:10
Stallergenes Greer, a global healthcare company specialising in allergen immunotherapy (AIT), today announced positive data from its EfficAPSI real-world study. Presented at the 2022 European Academy of Allergy and Clinical Immunology (EAACI)...

at 06:40
Seagen Inc. today announced full results from the pivotal phase 2 MOUNTAINEER trial, which showed TUKYSA® (tucatinib) in combination with trastuzumab was well-tolerated with durable responses in patients with previously treated HER2-positive...

at 00:00
Northern Utah Rehabilitation Hospital (NURH),nationally recognized as a healthcare leader for rehabilitative care for six years in a row (2015 to 2020), is proud to hold a Neuro Day event on July 7th, 2022, from 11 am to 2 pm to showcase the latest...

1 jui 2022
Product photos are available: https://recalls-rappels.canada.ca/en/alert-recall/twa-fungi-brand-king-oyster-mushroom-recalled-due-listeria-monocytogenes Summary Brand(s): TWA FungiProduct: King Oyster MushroomCompanies: Kam Ding Investment Ltd.Issue:...

1 jui 2022
Nutricosmetics Market Facts at a Glance- Companies: 10+ ? Including ActivInside, Borba LLC, Functionalab, Herbalife Nutrition Ltd.,...

News published on 24 may 2022 at 08:17 and distributed by: